25 XP   0   0   10

Avanos Medical Inc
Buy, Hold or Sell?

Let's analyse Avanos together

PenkeI guess you are interested in Avanos Medical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avanos Medical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Avanos Medical Inc

I send you an email if I find something interesting about Avanos Medical Inc.

Quick analysis of Avanos (30 sec.)










What can you expect buying and holding a share of Avanos? (30 sec.)

How much money do you get?

How much money do you get?
$1.21
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$26.53
Expected worth in 1 year
$25.59
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
$0.26
Return On Investment
1.3%

For what price can you sell your share?

Current Price per Share
$19.91
Expected price per share
$18.05 - $20.25
How sure are you?
50%

1. Valuation of Avanos (5 min.)




Live pricePrice per Share (EOD)

$19.91

Intrinsic Value Per Share

$-14.89 - $22.07

Total Value Per Share

$11.64 - $48.60

2. Growth of Avanos (5 min.)




Is Avanos growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$1.2b-$17.7m-1.4%

How much money is Avanos making?

Current yearPrevious yearGrowGrow %
Making money-$15.4m$12.4m-$27.9m-180.6%
Net Profit Margin-9.1%6.0%--

How much money comes from the company's main activities?

3. Financial Health of Avanos (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#30 / 340

Most Revenue
#54 / 340

Most Profit
#289 / 340

Most Efficient
#156 / 340

What can you expect buying and holding a share of Avanos? (5 min.)

Welcome investor! Avanos's management wants to use your money to grow the business. In return you get a share of Avanos.

What can you expect buying and holding a share of Avanos?

First you should know what it really means to hold a share of Avanos. And how you can make/lose money.

Speculation

The Price per Share of Avanos is $19.91. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avanos.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avanos, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $26.53. Based on the TTM, the Book Value Change Per Share is $-0.24 per quarter. Based on the YOY, the Book Value Change Per Share is $0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.30 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avanos.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.231.1%-0.33-1.7%0.271.3%-0.08-0.4%-0.17-0.8%
Usd Book Value Change Per Share0.422.1%-0.24-1.2%0.371.8%-0.04-0.2%-0.45-2.3%
Usd Dividend Per Share0.000.0%0.301.5%1.206.1%0.311.6%0.954.8%
Usd Total Gains Per Share0.422.1%0.070.3%1.577.9%0.271.4%0.502.5%
Usd Price Per Share22.43-24.49-27.42-32.32-34.04-
Price to Earnings Ratio24.89--186.33-32.98--42.73--10.97-
Price-to-Total Gains Ratio53.82-147.96-950.62-188.55-920.56-
Price to Book Ratio0.85-0.92-1.03-1.22-1.30-
Price-to-Total Gains Ratio53.82-147.96-950.62-188.55-920.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share19.91
Number of shares50
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.300.31
Usd Book Value Change Per Share-0.24-0.04
Usd Total Gains Per Share0.070.27
Gains per Quarter (50 shares)3.3113.59
Gains per Year (50 shares)13.2454.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
160-47363-844
2121-9416125-1798
3181-14129188-25152
4241-18842251-33206
5302-23655314-42260
6362-28368376-50314
7423-33081439-59368
8483-37794502-67422
9543-424107565-75476
10604-471120627-84530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%7.05.00.058.3%9.011.00.045.0%25.015.00.062.5%30.015.00.066.7%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%9.011.00.045.0%26.014.00.065.0%28.015.02.062.2%
Dividend per Share2.00.02.050.0%5.00.07.041.7%7.00.013.035.0%12.00.028.030.0%12.00.033.026.7%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%11.09.00.055.0%29.011.00.072.5%31.012.02.068.9%

Fundamentals of Avanos

About Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Fundamental data was last updated by Penke on 2024-03-22 16:02:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Avanos Medical Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avanos earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Net Profit Margin of 6.1% means that $0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avanos Medical Inc:

  • The MRQ is 6.1%. The company is making a profit. +1
  • The TTM is -9.1%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ6.1%TTM-9.1%+15.2%
TTM-9.1%YOY6.0%-15.2%
TTM-9.1%5Y-2.6%-6.5%
5Y-2.6%10Y-2.6%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%-10.6%+16.7%
TTM-9.1%-20.2%+11.1%
YOY6.0%-14.0%+20.0%
5Y-2.6%-19.5%+16.9%
10Y-2.6%-23.8%+21.2%
1.1.2. Return on Assets

Shows how efficient Avanos is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • 0.6% Return on Assets means that Avanos generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avanos Medical Inc:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.6%TTM-0.9%+1.5%
TTM-0.9%YOY0.7%-1.6%
TTM-0.9%5Y-0.2%-0.7%
5Y-0.2%10Y-0.4%+0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%-3.0%+3.6%
TTM-0.9%-4.2%+3.3%
YOY0.7%-4.0%+4.7%
5Y-0.2%-3.8%+3.6%
10Y-0.4%-4.1%+3.7%
1.1.3. Return on Equity

Shows how efficient Avanos is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • 0.8% Return on Equity means Avanos generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avanos Medical Inc:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -1.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.8%TTM-1.3%+2.1%
TTM-1.3%YOY1.0%-2.2%
TTM-1.3%5Y-0.3%-0.9%
5Y-0.3%10Y-0.8%+0.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-3.5%+4.3%
TTM-1.3%-4.4%+3.1%
YOY1.0%-4.7%+5.7%
5Y-0.3%-5.7%+5.4%
10Y-0.8%-6.2%+5.4%

1.2. Operating Efficiency of Avanos Medical Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avanos is operating .

  • Measures how much profit Avanos makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • An Operating Margin of 12.8% means the company generated $0.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avanos Medical Inc:

  • The MRQ is 12.8%. The company is operating less efficient.
  • The TTM is 3.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ12.8%TTM3.6%+9.2%
TTM3.6%YOY8.8%-5.2%
TTM3.6%5Y0.0%+3.6%
5Y0.0%10Y3.0%-2.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ12.8%-24.5%+37.3%
TTM3.6%-14.9%+18.5%
YOY8.8%-11.5%+20.3%
5Y0.0%-17.1%+17.1%
10Y3.0%-20.6%+23.6%
1.2.2. Operating Ratio

Measures how efficient Avanos is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.87 means that the operating costs are $0.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.872. The company is less efficient in keeping operating costs low.
  • The TTM is 0.966. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.872TTM0.966-0.094
TTM0.966YOY0.912+0.054
TTM0.9665Y1.002-0.037
5Y1.00210Y0.949+0.054
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8721.454-0.582
TTM0.9661.452-0.486
YOY0.9121.434-0.522
5Y1.0021.432-0.430
10Y0.9491.366-0.417

1.3. Liquidity of Avanos Medical Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avanos is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.08 means the company has $2.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avanos Medical Inc:

  • The MRQ is 2.076. The company is able to pay all its short-term debts. +1
  • The TTM is 2.793. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.076TTM2.793-0.717
TTM2.793YOY2.838-0.045
TTM2.7935Y2.846-0.053
5Y2.84610Y2.547+0.299
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0762.789-0.713
TTM2.7932.7930.000
YOY2.8383.586-0.748
5Y2.8463.492-0.646
10Y2.5473.450-0.903
1.3.2. Quick Ratio

Measures if Avanos is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Quick Ratio of 0.98 means the company can pay off $0.98 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.983. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.356. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.983TTM1.356-0.373
TTM1.356YOY1.655-0.299
TTM1.3565Y1.701-0.345
5Y1.70110Y1.437+0.264
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9831.587-0.604
TTM1.3561.633-0.277
YOY1.6552.185-0.530
5Y1.7012.300-0.599
10Y1.4372.255-0.818

1.4. Solvency of Avanos Medical Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avanos assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avanos to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.27 means that Avanos assets are financed with 26.9% credit (debt) and the remaining percentage (100% - 26.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.269. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.268. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.269TTM0.268+0.002
TTM0.268YOY0.285-0.017
TTM0.2685Y0.269-0.001
5Y0.26910Y0.326-0.057
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2690.400-0.131
TTM0.2680.386-0.118
YOY0.2850.330-0.045
5Y0.2690.440-0.171
10Y0.3260.460-0.134
1.4.2. Debt to Equity Ratio

Measures if Avanos is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Debt to Equity ratio of 36.9% means that company has $0.37 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.369. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.366. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.369TTM0.366+0.002
TTM0.366YOY0.399-0.032
TTM0.3665Y0.370-0.004
5Y0.37010Y0.519-0.148
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3690.566-0.197
TTM0.3660.569-0.203
YOY0.3990.479-0.080
5Y0.3700.626-0.256
10Y0.5190.692-0.173

2. Market Valuation of Avanos Medical Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avanos generates.

  • Above 15 is considered overpriced but always compare Avanos to the Medical Devices industry mean.
  • A PE ratio of 24.89 means the investor is paying $24.89 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avanos Medical Inc:

  • The EOD is 22.091. Based on the earnings, the company is fair priced.
  • The MRQ is 24.887. Based on the earnings, the company is fair priced.
  • The TTM is -186.327. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.091MRQ24.887-2.796
MRQ24.887TTM-186.327+211.214
TTM-186.327YOY32.982-219.309
TTM-186.3275Y-42.729-143.598
5Y-42.72910Y-10.966-31.763
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD22.091-1.038+23.129
MRQ24.887-1.216+26.103
TTM-186.327-1.757-184.570
YOY32.982-2.582+35.564
5Y-42.729-1.553-41.176
10Y-10.966-1.463-9.503
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avanos Medical Inc:

  • The EOD is 34.111. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 38.428. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -7.497. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD34.111MRQ38.428-4.317
MRQ38.428TTM-7.497+45.925
TTM-7.497YOY-22.194+14.697
TTM-7.4975Y-30.896+23.398
5Y-30.89610Y-44.813+13.917
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD34.111-1.207+35.318
MRQ38.428-1.746+40.174
TTM-7.497-2.961-4.536
YOY-22.194-6.143-16.051
5Y-30.896-4.928-25.968
10Y-44.813-5.626-39.187
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avanos is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.85 means the investor is paying $0.85 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avanos Medical Inc:

  • The EOD is 0.750. Based on the equity, the company is cheap. +2
  • The MRQ is 0.845. Based on the equity, the company is cheap. +2
  • The TTM is 0.917. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.750MRQ0.845-0.095
MRQ0.845TTM0.917-0.072
TTM0.917YOY1.027-0.110
TTM0.9175Y1.218-0.301
5Y1.21810Y1.296-0.078
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.7502.038-1.288
MRQ0.8452.321-1.476
TTM0.9172.444-1.527
YOY1.0273.028-2.001
5Y1.2183.918-2.700
10Y1.2964.245-2.949
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avanos Medical Inc.

3.1. Institutions holding Avanos Medical Inc

Institutions are holding 98.896% of the shares of Avanos Medical Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc16.1490.004374613433278664.5962
2023-09-30Vanguard Group Inc11.84860.0027547440820860.0381
2023-12-31RGM Capital LLC6.86422.915231714552197647.4454
2023-12-31Dimensional Fund Advisors, Inc.6.17760.01872854235-55750-1.9158
2023-09-30Paradice Investment Management LLC4.91913.94032272758283231.2619
2023-09-30Westwood Holdings Group Inc4.56520.3978210927339423422.9869
2023-09-30State Street Corporation4.30660.00221989756-57563-2.8116
2023-12-31T. Rowe Price Investment Management,Inc.4.01680.0271185586822878514.0611
2023-12-31William Blair Investment Management, LLC2.6410.0797122021012553511.4678
2023-09-30Geode Capital Management, LLC2.05130.0023947746371804.0832
2023-09-30Neuberger Berman Group LLC1.97820.0169913998107031.1849
2023-09-30Goldman Sachs Group Inc1.54690.0029714709-246233-25.6241
2023-12-31Tributary Capital Management, LLC1.49471.3039690590-16532-2.3379
2023-09-30Royal Bank of Canada1.34540.0034621603-9206-1.4594
2023-09-30Charles Schwab Investment Management Inc1.23460.0033570442348256.5018
2023-09-30Northern Trust Corp1.12280.002518767-65308-11.1814
2023-09-30Bank of New York Mellon Corp0.98040.002452975-10184-2.1988
2023-09-30Morgan Stanley - Brokerage Accounts0.95940.0009443269168693.9561
2023-09-30Ameriprise Financial Inc0.9470.00294375567648021.1811
2023-12-31Alberta Investment Management Corp0.89480.08724134185882616.5898
Total 76.04368.815735134379+1100700+3.1%

3.2. Funds holding Avanos Medical Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29iShares Core S&P Small-Cap ETF6.90280.0765318929051660.1622
2024-02-29Vanguard Total Stock Mkt Idx Inv3.13660.0017144921900
2024-02-29Vanguard Small Cap Index2.58980.01581196569109990.9277
2023-12-31T. Rowe Price Small-Cap Value2.46980.242114110012550012.3572
2024-02-29iShares Russell 2000 ETF2.41440.03321115542-182-0.0163
2024-02-29Vanguard Small Cap Value Index Inv1.76990.028681776331370.3851
2023-12-31Westwood Quality SmallCap Fund Inst1.69831.484578464500
2023-12-31Westwood Mgt SmallCap Value1.69831.480778464500
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.50340.01266946064390.0632
2024-02-29Brown Advisory Small-Cap Fdmtl Val Inv1.48950.958968818221571645.6575
2024-02-29iShares S&P Small-Cap 600 Value ETF1.27640.155658974416290.277
2024-01-31DFA US Small Cap Value I1.25570.073658018100
2024-02-29Tributary Small Cap Equity1.2391.229457247851400.906
2024-01-31William Blair Small Cap Value I1.18590.82035479117259415.2728
2023-12-31T. Rowe Price U.S. SC Value Eq Tr-Z1.14150.23955274147605316.8497
2024-02-29Tributary Small Company Instl1.03391.229247771257021.208
2023-12-31Fidelity Small Cap Index0.99090.040445784657011.2609
2024-02-01iShares Russell 2000 Value ETF0.92690.07054282705420.1267
2024-02-29SPDR® Portfolio S&P 600 Sm Cap ETF0.90810.0759419554860.0205
2024-02-29Vanguard Tax-Managed Small Cap Adm0.79130.076436562400
Total 36.42248.345316828295+528222+3.1%

3.3. Insider Transactions

Insiders are holding 2.843% of the shares of Avanos Medical Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-14Michael GreinerSELL800019.12
2024-03-11Julie Ann ShimerBUY50019.85

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Avanos Medical Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.417-0.236+157%0.367+14%-0.042+110%-0.454+209%
Book Value Per Share--26.53026.6360%26.734-1%26.5480%27.690-4%
Current Ratio--2.0762.793-26%2.838-27%2.846-27%2.547-18%
Debt To Asset Ratio--0.2690.268+1%0.285-5%0.269+0%0.326-17%
Debt To Equity Ratio--0.3690.366+1%0.399-7%0.3700%0.519-29%
Dividend Per Share---0.302-100%1.205-100%0.314-100%0.951-100%
Eps--0.225-0.330+246%0.267-16%-0.084+137%-0.167+174%
Free Cash Flow Per Share--0.1460.079+86%0.380-62%0.005+2907%0.092+58%
Free Cash Flow To Equity Per Share---2.315-0.426-82%0.673-444%-0.166-93%-0.173-93%
Gross Profit Margin--1.0001.0000%1.0000%0.797+25%0.898+11%
Intrinsic Value_10Y_max--22.071--------
Intrinsic Value_10Y_min---14.889--------
Intrinsic Value_1Y_max--1.234--------
Intrinsic Value_1Y_min--0.053--------
Intrinsic Value_3Y_max--4.452--------
Intrinsic Value_3Y_min---1.178--------
Intrinsic Value_5Y_max--8.569--------
Intrinsic Value_5Y_min---3.865--------
Market Cap919923631.000-14%1045238000.0001147867500.000-9%1299541000.000-20%1541645100.000-32%1614250766.000-35%
Net Profit Margin--0.061-0.091+251%0.060+1%-0.026+143%-0.026+142%
Operating Margin--0.1280.036+255%0.088+45%0.000+42355%0.030+331%
Operating Ratio--0.8720.966-10%0.912-4%1.002-13%0.949-8%
Pb Ratio0.750-13%0.8450.917-8%1.027-18%1.218-31%1.296-35%
Pe Ratio22.091-13%24.887-186.327+849%32.982-25%-42.729+272%-10.966+144%
Price Per Share19.910-13%22.43024.488-8%27.420-18%32.324-31%34.040-34%
Price To Free Cash Flow Ratio34.111-13%38.428-7.497+120%-22.194+158%-30.896+180%-44.813+217%
Price To Total Gains Ratio47.769-13%53.815147.964-64%950.617-94%188.550-71%920.564-94%
Quick Ratio--0.9831.356-28%1.655-41%1.701-42%1.437-32%
Return On Assets--0.006-0.009+249%0.007-12%-0.002+140%-0.004+168%
Return On Equity--0.008-0.013+247%0.010-13%-0.003+139%-0.008+195%
Total Gains Per Share--0.4170.066+529%1.571-73%0.272+53%0.497-16%
Usd Book Value--1236300000.0001247975000.000-1%1265700000.000-2%1264150000.000-2%1308920000.000-6%
Usd Book Value Change Per Share--0.417-0.236+157%0.367+14%-0.042+110%-0.454+209%
Usd Book Value Per Share--26.53026.6360%26.734-1%26.5480%27.690-4%
Usd Dividend Per Share---0.302-100%1.205-100%0.314-100%0.951-100%
Usd Eps--0.225-0.330+246%0.267-16%-0.084+137%-0.167+174%
Usd Free Cash Flow--6800000.0003650000.000+86%17900000.000-62%235000.000+2794%4182500.000+63%
Usd Free Cash Flow Per Share--0.1460.079+86%0.380-62%0.005+2907%0.092+58%
Usd Free Cash Flow To Equity Per Share---2.315-0.426-82%0.673-444%-0.166-93%-0.173-93%
Usd Market Cap919923631.000-14%1045238000.0001147867500.000-9%1299541000.000-20%1541645100.000-32%1614250766.000-35%
Usd Price Per Share19.910-13%22.43024.488-8%27.420-18%32.324-31%34.040-34%
Usd Profit--10500000.000-15450000.000+247%12450000.000-16%-3995000.000+138%-7562500.000+172%
Usd Revenue--173300000.000176425000.000-2%205000000.000-15%184135000.000-6%244635000.000-29%
Usd Total Gains Per Share--0.4170.066+529%1.571-73%0.272+53%0.497-16%
 EOD+4 -4MRQTTM+17 -18YOY+10 -255Y+19 -1710Y+18 -18

4.2. Fundamental Score

Let's check the fundamental score of Avanos Medical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.091
Price to Book Ratio (EOD)Between0-10.750
Net Profit Margin (MRQ)Greater than00.061
Operating Margin (MRQ)Greater than00.128
Quick Ratio (MRQ)Greater than10.983
Current Ratio (MRQ)Greater than12.076
Debt to Asset Ratio (MRQ)Less than10.269
Debt to Equity Ratio (MRQ)Less than10.369
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.006
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Avanos Medical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.920
Ma 20Greater thanMa 5019.432
Ma 50Greater thanMa 10019.284
Ma 100Greater thanMa 20020.229
OpenGreater thanClose19.870
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,692,400
Total Liabilities456,100
Total Stockholder Equity1,236,300
 As reported
Total Liabilities 456,100
Total Stockholder Equity+ 1,236,300
Total Assets = 1,692,400

Assets

Total Assets1,692,400
Total Current Assets487,000
Long-term Assets1,205,400
Total Current Assets
Cash And Cash Equivalents 87,700
Net Receivables 142,800
Inventory 163,200
Other Current Assets 93,300
Total Current Assets  (as reported)487,000
Total Current Assets  (calculated)487,000
+/-0
Long-term Assets
Property Plant Equipment 144,000
Goodwill 796,100
Intangible Assets 239,500
Long-term Assets Other 19,300
Long-term Assets  (as reported)1,205,400
Long-term Assets  (calculated)1,198,900
+/- 6,500

Liabilities & Shareholders' Equity

Total Current Liabilities234,600
Long-term Liabilities221,500
Total Stockholder Equity1,236,300
Total Current Liabilities
Short-term Debt 21,400
Short Long Term Debt 8,600
Accounts payable 56,300
Other Current Liabilities 156,900
Total Current Liabilities  (as reported)234,600
Total Current Liabilities  (calculated)243,200
+/- 8,600
Long-term Liabilities
Long term Debt 159,400
Capital Lease Obligations 41,100
Long-term Liabilities Other 4,100
Long-term Liabilities  (as reported)221,500
Long-term Liabilities  (calculated)204,600
+/- 16,900
Total Stockholder Equity
Common Stock500
Accumulated Other Comprehensive Income -27,000
Other Stockholders Equity 1,236,300
Total Stockholder Equity (as reported)1,236,300
Total Stockholder Equity (calculated)1,209,800
+/- 26,500
Other
Capital Stock500
Cash and Short Term Investments 87,700
Common Stock Shares Outstanding 46,600
Liabilities and Stockholders Equity 1,692,400
Net Debt 121,400
Net Invested Capital 1,404,300
Net Working Capital 252,400
Property Plant and Equipment Gross 266,900
Short Long Term Debt Total 209,100



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
2,534,200
0
0
0
2,484,000
2,463,400
2,456,300
2,449,400
2,527,600
2,536,400
2,485,500
2,006,300
2,000,200
2,019,700
2,112,000
2,095,000
2,071,800
2,086,400
2,124,900
2,148,900
2,195,900
2,202,900
1,917,400
1,844,500
1,833,400
1,834,000
1,783,400
1,807,700
1,799,600
1,763,700
1,755,900
1,799,100
1,672,800
1,648,800
1,683,300
1,597,900
1,594,600
1,766,500
1,752,800
1,775,200
1,786,900
1,734,900
1,666,700
1,724,900
1,692,400
1,692,4001,724,9001,666,7001,734,9001,786,9001,775,2001,752,8001,766,5001,594,6001,597,9001,683,3001,648,8001,672,8001,799,1001,755,9001,763,7001,799,6001,807,7001,783,4001,834,0001,833,4001,844,5001,917,4002,202,9002,195,9002,148,9002,124,9002,086,4002,071,8002,095,0002,112,0002,019,7002,000,2002,006,3002,485,5002,536,4002,527,6002,449,4002,456,3002,463,4002,484,0000002,534,200
   > Total Current Assets 
0
0
0
0
585,100
571,400
598,300
596,100
684,900
703,100
653,100
666,000
676,000
706,600
609,700
605,600
593,500
614,400
654,800
681,000
1,160,700
1,161,100
876,500
737,200
713,600
660,000
572,500
546,500
538,500
524,100
517,100
567,600
467,200
447,900
443,500
405,000
418,600
439,200
437,100
470,000
499,800
453,800
506,900
524,600
487,000
487,000524,600506,900453,800499,800470,000437,100439,200418,600405,000443,500447,900467,200567,600517,100524,100538,500546,500572,500660,000713,600737,200876,5001,161,1001,160,700681,000654,800614,400593,500605,600609,700706,600676,000666,000653,100703,100684,900596,100598,300571,400585,1000000
       Cash And Cash Equivalents 
47,900
0
0
0
44,100
35,800
48,500
58,400
149,000
166,200
114,300
112,500
129,500
165,100
79,200
86,700
113,700
143,100
154,800
166,100
219,700
203,100
479,600
411,800
384,500
348,300
288,100
214,400
205,300
187,700
185,000
180,000
111,500
100,100
99,900
97,800
118,500
104,300
106,500
117,000
127,700
95,700
81,800
107,100
87,700
87,700107,10081,80095,700127,700117,000106,500104,300118,50097,80099,900100,100111,500180,000185,000187,700205,300214,400288,100348,300384,500411,800479,600203,100219,700166,100154,800143,100113,70086,70079,200165,100129,500112,500114,300166,200149,00058,40048,50035,80044,10000047,900
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000051,5000000000000000000000000
       Net Receivables 
0
0
0
0
203,300
197,900
195,300
192,200
233,900
226,500
200,100
204,400
224,700
206,300
195,200
189,100
190,100
181,200
184,100
194,400
203,000
199,500
189,200
151,800
150,500
135,000
124,300
157,700
163,800
159,600
137,800
182,300
167,900
164,300
165,100
129,100
131,200
161,600
145,400
146,200
167,900
142,700
152,300
145,200
142,800
142,800145,200152,300142,700167,900146,200145,400161,600131,200129,100165,100164,300167,900182,300137,800159,600163,800157,700124,300135,000150,500151,800189,200199,500203,000194,400184,100181,200190,100189,100195,200206,300224,700204,400200,100226,500233,900192,200195,300197,900203,3000000
       Other Current Assets 
60,400
0
0
0
52,100
51,900
53,200
50,800
16,800
17,400
14,800
25,500
18,600
26,800
25,000
31,100
17,200
16,700
19,700
20,000
14,400
15,800
48,400
52,400
57,200
47,100
26,200
29,900
23,500
23,700
20,200
21,200
18,900
18,300
18,800
19,700
18,600
15,700
16,200
13,200
13,900
15,400
15,800
13,600
93,300
93,30013,60015,80015,40013,90013,20016,20015,70018,60019,70018,80018,30018,90021,20020,20023,70023,50029,90026,20047,10057,20052,40048,40015,80014,40020,00019,70016,70017,20031,10025,00026,80018,60025,50014,80017,40016,80050,80053,20051,90052,10000060,400
   > Long-term Assets 
0
0
0
0
1,898,900
1,892,000
1,858,000
1,853,300
1,842,700
1,833,300
1,832,400
1,340,300
1,324,200
1,313,100
1,502,300
1,489,400
1,478,300
1,472,000
1,470,100
1,467,900
1,035,200
1,041,800
1,040,900
1,107,300
1,119,800
1,174,000
1,210,900
1,261,200
1,261,100
1,239,600
1,238,800
1,231,500
1,205,600
1,200,900
1,239,800
1,192,900
1,176,000
1,327,300
1,315,700
1,305,200
1,287,100
1,281,100
1,159,800
1,200,300
1,205,400
1,205,4001,200,3001,159,8001,281,1001,287,1001,305,2001,315,7001,327,3001,176,0001,192,9001,239,8001,200,9001,205,6001,231,5001,238,8001,239,6001,261,1001,261,2001,210,9001,174,0001,119,8001,107,3001,040,9001,041,8001,035,2001,467,9001,470,1001,472,0001,478,3001,489,4001,502,3001,313,1001,324,2001,340,3001,832,4001,833,3001,842,7001,853,3001,858,0001,892,0001,898,9000000
       Property Plant Equipment 
325,700
0
0
0
324,900
326,000
284,900
292,800
277,800
281,800
286,000
282,100
279,500
275,600
272,600
265,000
260,800
258,300
259,700
261,100
109,900
117,500
123,500
137,000
154,100
214,500
241,600
246,100
248,500
238,600
239,300
233,800
223,600
218,500
214,800
211,100
206,700
203,000
198,200
195,900
194,500
191,800
151,700
143,900
144,000
144,000143,900151,700191,800194,500195,900198,200203,000206,700211,100214,800218,500223,600233,800239,300238,600248,500246,100241,600214,500154,100137,000123,500117,500109,900261,100259,700258,300260,800265,000272,600275,600279,500282,100286,000281,800277,800292,800284,900326,000324,900000325,700
       Goodwill 
1,434,100
0
0
0
1,430,100
1,430,800
1,432,800
1,429,000
1,426,100
1,422,100
1,422,800
943,400
945,200
946,800
1,031,600
1,031,900
1,029,000
1,029,700
1,030,900
1,032,000
764,700
764,600
763,800
786,700
783,600
783,700
782,300
800,500
800,900
799,800
800,200
801,200
802,500
802,100
802,600
801,800
801,600
826,000
825,000
823,600
819,400
821,500
762,600
791,500
796,100
796,100791,500762,600821,500819,400823,600825,000826,000801,600801,800802,600802,100802,500801,200800,200799,800800,900800,500782,300783,700783,600786,700763,800764,600764,7001,032,0001,030,9001,029,7001,029,0001,031,9001,031,600946,800945,200943,4001,422,8001,422,1001,426,1001,429,0001,432,8001,430,8001,430,1000001,434,100
       Intangible Assets 
1,610,900
0
0
0
141,200
132,500
125,100
116,300
108,300
101,800
95,400
89,000
82,600
77,400
182,400
176,700
169,800
164,400
159,800
154,800
148,900
144,600
139,500
173,900
168,200
163,200
158,500
189,500
184,300
179,300
174,600
170,100
157,700
153,600
149,500
145,300
141,200
271,100
264,900
258,700
251,000
244,700
222,600
242,200
239,500
239,500242,200222,600244,700251,000258,700264,900271,100141,200145,300149,500153,600157,700170,100174,600179,300184,300189,500158,500163,200168,200173,900139,500144,600148,900154,800159,800164,400169,800176,700182,40077,40082,60089,00095,400101,800108,300116,300125,100132,500141,2000001,610,900
       Long-term Assets Other 
0
0
0
0
2,700
2,700
15,200
15,200
30,500
27,600
28,200
25,800
2,000
2,000
3,700
3,600
3,600
3,800
3,600
3,700
4,100
3,800
3,500
3,400
7,600
6,400
15,200
12,800
11,300
10,900
10,700
14,400
11,800
11,300
11,000
11,100
16,500
15,900
16,500
16,100
17,600
18,600
18,500
18,400
19,300
19,30018,40018,50018,60017,60016,10016,50015,90016,50011,10011,00011,30011,80014,40010,70010,90011,30012,80015,2006,4007,6003,4003,5003,8004,1003,7003,6003,8003,6003,6003,7002,0002,00025,80028,20027,60030,50015,20015,2002,7002,7000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
14,900
11,300
12,000
12,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000012,20012,00011,30014,900000000000000
> Total Liabilities 
478,500
0
0
0
404,900
359,900
379,000
370,400
1,036,400
1,024,600
963,700
965,300
944,900
939,900
1,022,500
993,500
969,300
955,500
968,100
968,200
980,500
951,100
630,800
544,300
536,200
553,900
506,500
540,800
534,400
507,200
494,300
509,200
416,300
396,200
387,000
336,000
330,700
510,000
501,200
511,700
495,700
436,200
431,900
502,800
456,100
456,100502,800431,900436,200495,700511,700501,200510,000330,700336,000387,000396,200416,300509,200494,300507,200534,400540,800506,500553,900536,200544,300630,800951,100980,500968,200968,100955,500969,300993,5001,022,500939,900944,900965,300963,7001,024,6001,036,400370,400379,000359,900404,900000478,500
   > Total Current Liabilities 
359,100
0
0
0
310,400
265,300
283,800
277,900
356,000
341,000
324,000
326,800
315,200
309,300
304,900
310,700
324,400
310,000
321,800
319,400
389,800
360,600
352,800
265,500
264,300
238,400
187,000
218,100
212,500
189,400
176,000
179,400
166,300
154,600
158,300
129,200
139,200
152,900
151,100
162,300
185,800
158,500
160,500
170,700
234,600
234,600170,700160,500158,500185,800162,300151,100152,900139,200129,200158,300154,600166,300179,400176,000189,400212,500218,100187,000238,400264,300265,500352,800360,600389,800319,400321,800310,000324,400310,700304,900309,300315,200326,800324,000341,000356,000277,900283,800265,300310,400000359,100
       Short-term Debt 
0
0
0
0
11,900
9,400
10,400
10,900
3,900
3,900
0
0
578,100
0
0
0
579,000
0
579,900
580,400
39,800
542,000
247,400
0
0
11,700
14,700
14,500
14,700
14,300
15,400
15,600
15,500
15,100
14,900
14,700
14,700
14,500
18,200
19,600
19,000
18,300
19,700
18,900
21,400
21,40018,90019,70018,30019,00019,60018,20014,50014,70014,70014,90015,10015,50015,60015,40014,30014,70014,50014,70011,70000247,400542,00039,800580,400579,9000579,000000578,100003,9003,90010,90010,4009,40011,9000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
3,900
0
0
0
578,100
0
0
0
579,000
0
579,900
580,400
39,800
542,000
247,400
0
0
11,700
0
0
0
0
0
0
0
0
0
0
0
0
4,700
6,200
6,200
6,200
6,200
6,200
8,600
8,6006,2006,2006,2006,2006,2004,70000000000000011,70000247,400542,00039,800580,400579,9000579,000000578,1000003,90000000000
       Accounts payable 
102,200
0
0
0
118,500
113,500
121,000
118,400
168,700
192,100
200,600
179,100
163,200
181,100
168,600
166,500
173,100
179,700
184,400
172,500
171,200
194,400
176,900
159,200
169,900
148,800
99,400
94,700
83,000
73,500
75,800
75,900
67,600
59,200
65,500
54,900
56,400
63,800
64,200
62,700
67,900
59,600
65,400
52,100
56,300
56,30052,10065,40059,60067,90062,70064,20063,80056,40054,90065,50059,20067,60075,90075,80073,50083,00094,70099,400148,800169,900159,200176,900194,400171,200172,500184,400179,700173,100166,500168,600181,100163,200179,100200,600192,100168,700118,400121,000113,500118,500000102,200
       Other Current Liabilities 
160,300
0
0
0
167,800
131,200
140,500
142,600
181,300
121,200
123,400
147,700
152,000
128,200
136,300
144,200
151,300
130,300
137,400
146,900
33,900
166,200
175,900
106,300
94,400
11,700
68,700
105,100
111,600
98,300
80,400
85,900
80,500
76,900
75,900
57,800
68,100
74,600
68,700
80,000
98,900
80,600
2,700
2,500
156,900
156,9002,5002,70080,60098,90080,00068,70074,60068,10057,80075,90076,90080,50085,90080,40098,300111,600105,10068,70011,70094,400106,300175,900166,20033,900146,900137,400130,300151,300144,200136,300128,200152,000147,700123,400121,200181,300142,600140,500131,200167,800000160,300
   > Long-term Liabilities 
0
0
0
0
94,500
94,600
95,200
92,500
680,400
683,600
639,700
638,500
629,700
630,600
717,600
682,800
644,900
645,500
646,300
648,800
590,700
590,500
278,000
278,800
271,900
315,500
319,500
322,700
321,900
317,800
318,300
329,800
250,000
241,600
228,700
206,800
191,500
357,100
350,100
349,400
309,900
277,700
271,400
332,100
221,500
221,500332,100271,400277,700309,900349,400350,100357,100191,500206,800228,700241,600250,000329,800318,300317,800321,900322,700319,500315,500271,900278,800278,000590,500590,700648,800646,300645,500644,900682,800717,600630,600629,700638,500639,700683,600680,40092,50095,20094,60094,5000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
632,300
631,400
585,800
585,900
578,100
578,500
624,000
589,400
579,000
579,400
579,900
580,400
541,100
542,000
247,400
247,600
247,700
247,900
247,800
247,900
248,100
248,200
248,400
248,500
180,000
175,000
165,000
145,000
130,000
254,400
249,300
247,800
226,300
204,700
0
0
0
000204,700226,300247,800249,300254,400130,000145,000165,000175,000180,000248,500248,400248,200248,100247,900247,800247,900247,700247,600247,400542,000541,100580,400579,900579,400579,000589,400624,000578,500578,100585,900585,800631,400632,30000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-11,900
-9,400
-10,400
-10,900
-3,900
-3,900
0
0
-578,100
0
0
0
-579,000
0
-579,900
-580,400
-39,800
-542,000
-247,400
0
0
57,700
65,500
62,500
62,600
58,800
58,900
56,100
53,300
50,100
47,500
46,100
42,800
40,000
33,700
30,600
28,500
26,200
24,700
23,300
19,700
19,70023,30024,70026,20028,50030,60033,70040,00042,80046,10047,50050,10053,30056,10058,90058,80062,60062,50065,50057,70000-247,400-542,000-39,800-580,400-579,9000-579,000000-578,10000-3,900-3,900-10,900-10,400-9,400-11,9000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
14,900
11,300
12,000
12,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000012,20012,00011,30014,900000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
48,100
0
0
0
27,800
28,200
30,200
30,000
30,100
29,900
30,000
31,900
31,800
30,200
29,600
30,100
19,800
63,200
71,100
74,300
73,800
69,600
69,900
67,500
64,300
61,000
4,900
56,200
51,900
68,000
23,500
64,600
18,700
15,500
15,400
15,600
4,100
4,10015,60015,40015,50018,70064,60023,50068,00051,90056,2004,90061,00064,30067,50069,90069,60073,80074,30071,10063,20019,80030,10029,60030,20031,80031,90030,00029,90030,10030,00030,20028,20027,80000048,10000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
23,800
23,900
63,400
63,400
35,800
36,200
36,400
36,500
17,800
18,300
1,000
1,100
4,400
4,400
600
500
0
0
0
13,800
5,700
5,600
5,600
5,600
9,600
34,700
34,700
37,000
25,400
25,100
21,800
0
0
0021,80025,10025,40037,00034,70034,7009,6005,6005,6005,6005,70013,8000005006004,4004,4001,1001,00018,30017,80036,50036,40036,20035,80063,40063,40023,90023,800000000000000
> Total Stockholder Equity
2,055,700
0
0
0
2,079,100
2,103,500
2,077,300
2,079,000
1,491,200
1,511,800
1,521,800
1,041,000
1,055,300
1,079,800
1,089,500
1,101,500
1,102,500
1,130,900
1,156,800
1,180,700
1,215,400
1,251,800
1,286,600
1,300,200
1,297,200
1,280,100
1,276,900
1,266,900
1,265,200
1,256,500
1,261,600
1,289,900
1,256,500
1,252,600
1,296,300
1,261,900
1,263,900
1,256,500
1,251,600
1,263,500
1,291,200
1,298,700
1,234,800
1,222,100
1,236,300
1,236,3001,222,1001,234,8001,298,7001,291,2001,263,5001,251,6001,256,5001,263,9001,261,9001,296,3001,252,6001,256,5001,289,9001,261,6001,256,5001,265,2001,266,9001,276,9001,280,1001,297,2001,300,2001,286,6001,251,8001,215,4001,180,7001,156,8001,130,9001,102,5001,101,5001,089,5001,079,8001,055,3001,041,0001,521,8001,511,8001,491,2002,079,0002,077,3002,103,5002,079,1000002,055,700
   Common Stock
0
0
0
0
0
0
0
0
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
50050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
7,300
29,000
36,900
-433,600
-419,000
-404,800
-398,300
-389,200
-379,200
-366,400
-349,300
-332,700
-299,900
-279,700
-244,400
-240,200
-242,400
-262,700
-270,700
-282,200
-288,300
-284,600
-287,600
-268,300
-315,500
-323,100
-285,200
-320,300
-310,300
-304,500
-293,100
-270,000
-253,100
-253,600
-321,700
0
0
00-321,700-253,600-253,100-270,000-293,100-304,500-310,300-320,300-285,200-323,100-315,500-268,300-287,600-284,600-288,300-282,200-270,700-262,700-242,400-240,200-244,400-279,700-299,900-332,700-349,300-366,400-379,200-389,200-398,300-404,800-419,000-433,60036,90029,0007,30000000000
   Accumulated Other Comprehensive Income -27,000-33,000-28,400-35,800-35,800-42,900-37,800-32,100-33,800-33,600-30,000-32,300-28,100-37,100-42,000-46,900-32,000-34,800-31,100-33,000-33,700-30,500-32,100-21,800-31,300-30,600-34,300-39,400-50,100-38,300-38,100-36,600-43,200-42,800-28,900-25,600-19,100-21,100-11,600-14,600-19,6000000
   Capital Surplus 
0
0
0
0
0
0
0
0
1,502,500
1,507,900
1,514,300
1,517,900
1,518,000
1,521,700
1,527,300
1,530,400
1,533,200
1,538,100
1,543,800
1,547,400
1,550,500
1,557,300
1,567,700
1,575,500
1,578,100
1,582,500
1,586,800
1,592,100
1,593,900
1,596,400
1,599,900
1,604,100
1,609,400
1,617,300
1,621,300
1,625,700
1,628,800
1,633,300
1,637,400
1,642,300
1,646,400
1,651,000
1,654,900
0
0
001,654,9001,651,0001,646,4001,642,3001,637,4001,633,3001,628,8001,625,7001,621,3001,617,3001,609,4001,604,1001,599,9001,596,4001,593,9001,592,1001,586,8001,582,5001,578,1001,575,5001,567,7001,557,3001,550,5001,547,4001,543,8001,538,1001,533,2001,530,4001,527,3001,521,7001,518,0001,517,9001,514,3001,507,9001,502,50000000000
   Treasury Stock0000000-40,700-21,300-10,400-10,300-9,800-9,800-9,300-9,200-8,900-8,900-8,700-8,600-7,200-5,300-5,100-5,100-4,500-4,400-3,900-3,900-1,900-1,900-1,900-1,900-1,000-1,000-1,000-1,0000000000000
   Other Stockholders Equity 
0
0
0
0
2,098,700
2,118,100
2,088,900
2,100,100
1,502,500
1,507,900
1,513,300
1,516,900
1,517,000
1,520,700
1,525,400
1,528,500
1,531,300
1,536,200
1,539,900
1,543,500
1,546,100
1,552,800
1,562,600
1,570,400
1,572,800
1,575,300
1,578,200
1,583,400
1,585,000
1,587,500
1,590,700
1,594,800
1,599,600
1,607,500
1,611,000
1,615,300
1,607,500
1,592,600
1,582,000
1,575,900
1,579,600
1,587,100
1,584,400
1,580,000
1,236,300
1,236,3001,580,0001,584,4001,587,1001,579,6001,575,9001,582,0001,592,6001,607,5001,615,3001,611,0001,607,5001,599,6001,594,8001,590,7001,587,5001,585,0001,583,4001,578,2001,575,3001,572,8001,570,4001,562,6001,552,8001,546,1001,543,5001,539,9001,536,2001,531,3001,528,5001,525,4001,520,7001,517,0001,516,9001,513,3001,507,9001,502,5002,100,1002,088,9002,118,1002,098,7000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue673,300
Cost of Revenue-290,600
Gross Profit382,700382,700
 
Operating Income (+$)
Gross Profit382,700
Operating Expense-330,300
Operating Income52,40052,400
 
Operating Expense (+$)
Research Development27,200
Selling General Administrative335,000
Selling And Marketing Expenses0
Operating Expense330,300362,200
 
Net Interest Income (+$)
Interest Income2,900
Interest Expense-15,000
Other Finance Cost-0
Net Interest Income-12,100
 
Pretax Income (+$)
Operating Income52,400
Net Interest Income-12,100
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,900112,700
EBIT - interestExpense = 37,400
-59,800
-46,800
Interest Expense15,000
Earnings Before Interest and Taxes (EBIT)52,4007,100
Earnings Before Interest and Taxes (EBITDA)98,500
 
After tax Income (+$)
Income Before Tax-7,900
Tax Provision-2,000
Net Income From Continuing Ops-9,900-9,900
Net Income-61,800
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses620,900
Total Other Income/Expenses Net-60,30012,100
 

Technical Analysis of Avanos
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avanos. The general trend of Avanos is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avanos's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Avanos Medical Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 19.93 < 20.21 < 20.25.

The bearish price targets are: 18.81 > 18.26 > 18.05.

Tweet this
Avanos Medical Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Avanos Medical Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Avanos Medical Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Avanos Medical Inc. The current macd is 0.10639422.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Avanos price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Avanos. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Avanos price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Avanos Medical Inc Daily Moving Average Convergence/Divergence (MACD) ChartAvanos Medical Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Avanos Medical Inc. The current adx is 13.81.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Avanos shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Avanos Medical Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Avanos Medical Inc. The current sar is 18.83.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Avanos Medical Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Avanos Medical Inc. The current rsi is 58.92. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Avanos Medical Inc Daily Relative Strength Index (RSI) ChartAvanos Medical Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Avanos Medical Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Avanos price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Avanos Medical Inc Daily Stochastic Oscillator ChartAvanos Medical Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Avanos Medical Inc. The current cci is 107.58.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Avanos Medical Inc Daily Commodity Channel Index (CCI) ChartAvanos Medical Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Avanos Medical Inc. The current cmo is 32.49.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Avanos Medical Inc Daily Chande Momentum Oscillator (CMO) ChartAvanos Medical Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Avanos Medical Inc. The current willr is -21.42295878.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Avanos is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Avanos Medical Inc Daily Williams %R ChartAvanos Medical Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Avanos Medical Inc.

Avanos Medical Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Avanos Medical Inc. The current atr is 0.47636061.

Avanos Medical Inc Daily Average True Range (ATR) ChartAvanos Medical Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Avanos Medical Inc. The current obv is -582,320.

Avanos Medical Inc Daily On-Balance Volume (OBV) ChartAvanos Medical Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Avanos Medical Inc. The current mfi is 43.37.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Avanos Medical Inc Daily Money Flow Index (MFI) ChartAvanos Medical Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Avanos Medical Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Avanos Medical Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Avanos Medical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.920
Ma 20Greater thanMa 5019.432
Ma 50Greater thanMa 10019.284
Ma 100Greater thanMa 20020.229
OpenGreater thanClose19.870
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Avanos with someone you think should read this too:
  • Are you bullish or bearish on Avanos? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avanos? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Avanos Medical Inc

I send you an email if I find something interesting about Avanos Medical Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Avanos Medical Inc.

Receive notifications about Avanos Medical Inc in your mailbox!